In May 2010, the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Noncancer Pain was released by the National Opioid Use Guideline Group (NOUGG). 1 NOUGG formed under the guidance of the Federation of Medical Regulatory Authorities of Canada with support and/or representation from all provincial and territorial medical regulatory authorities (MRAs) in Canada. Canadian MRAs undertook this guideline development in response to physicians and other stakeholders seeking guidance regarding safe and effective use of opioids; a growing concern about opioid misuse creating patient and public safety issues and the lack of systematically developed national guidelines on opioid use for chronic noncancer pain. The ultimate goal of the Canadian Opioid Guideline is to promote safe and effective use of opioids for chronic noncancer pain. However, the 164-page document containing 24 recommendations seem overwhelming to the busy physician.
The "knowledge-to-action" framework developed by Graham et al. 2 states that the process to support improvements in quality of healthcare involves two major concepts: knowledge creation and action. The first concept was achieved with the knowledge inquiry and synthesis for the guideline's development. The second concept is the focus of the OPIOID MANAGER tool. This study focused on the development of the OPIOID MANAGER and future plans to its continued improvement.
METHODS
The OPIOID MANAGER is designed to be used as a point-of-care tool for providers prescribing and dispensing opioids for chronic noncancer pain. It condenses key elements from the Canadian Opioid Guideline and can be used as a chart insert. The OPIOID MANAGER contains reminders about overdose risk, an initiation checklist, the Opioid Risk Tool, 3 suggested initial doses and titration, a morphine equivalence table, a stepped approach to opioid selection, information about when and how to stop opioids, and a list of aberrant drug-related behaviours. 4 The development of the OPIOID MANAGER was entirely funded by the Alternative Funding Plan (AFP) Innovation Fund from the Ontario Ministry of Health and Long Term Care. The OPIOID MANAGER is free for download from the Guideline's Web site (http://nationalpaincentre. mcmaster.ca/opioidmanager/).
Preliminary drafts
The initial draft of the OPIOID MANAGER was developed by a team comprising the physician who led the research team for the development of the Canadian Opioid Guideline (Andrea Furlan), the NOUGG co-chair (Rhoda Reardon), the Director of Knowledge Support Services at the Centre for Effective Practice in Toronto (Lena Salach), and a psychiatrist consultant (Jose Silveira). The individual components to be included in the OPIOID MAN-AGER were selected from the tables, charts, and tools included in the Opioid Guideline. New initiation trial chart and maintenance and monitoring chart were developed exclusively for the purpose of the OPIOID MANAGER. The preliminary draft was sent for feedback to four physiatrists with interest in chronic noncancer pain, one family physician with interest in addiction medicine, and one family physician who practices comprehensive medicine.
First draft
The first draft was released simultaneously with the Canadian Opioid Guideline on May 3, 2010. Interested users registered to the Web site to download the color or black and white versions of the OPI-OID MANAGER. From May to December 2010, there was a note in the first draft of the OPIOID MANAGER inviting users to provide feedback regarding its content, layout, and usability. An electronic, anonymous survey was posted in SurveyMonkey® (a web-based free service intended for conducting surveys) and it was closed on December 31, 2010. It contained the following questions:
1. Professional designation: family physician/general practitioner, other physician, nurse practitioner, registered nurse, pharmacist, or other profession.
2. Practice location: remote, rural, suburban, or urban. 10. Please share any further comments you might have regarding the content, format, and usability of this tool.
Is there information in the Opioid

Final version
The same team that developed the preliminary drafts assessed the results from the electronic survey. The results were tabulated quantitatively. Written comments were analyzed qualitatively by themes. We also invited comments and feedback from the Guideline's National Faculty members. The National Faculty comprises ~35 people (representing nine provinces, one territory, and eight national associations) and has the goal to disseminate, implement to practice, and evaluate the Guideline's impact. The final version of the OPIOID MANAGER was released in February 2011 and replaced the first draft on the Guideline's Web site.
RESULTS
Electronic survey results
In total, 71 people started the electronic survey from May to December 2010. Sixty-eight answered the question regarding their professional designation: 30 family physicians/general practitioner (44.1 percent), 13 pharmacist (19.1 percent), 12 other physician (17.6 percent), 4 nurses (6 percent), and 10 miscellaneous other (14.7 percent). Sixty-six answered the question about their practice location: 33 urban (50 percent), 17 suburban (25.8 percent), 13 rural (19.7 percent), and 3 remote (4.5 percent).
The answers to the remaining questions are shown in Table 1 . Various members of the National Faculty provided direct comments via e-mail or by responding to the electronic survey. Thirteen people (37 percent) answered that there was information missing that they needed to safely and effectively prescribe opioids. The analyses of the written comments suggested that the information missing was related to 1) monitoring results of the urine drug screening, 2) monitoring aberrant drug-related behaviors, 3) automatic calculations of morphine equivalents, 4) recommendation of how often the physician should be seeing the patients, and 5) information regarding pregnant/breastfeeding patients. However, the main suggestions for change were in the layout and content of the initiation trial chart and maintenance and monitoring chart.
The main changes to the OPIOID MANAGER in response to the electronic survey were in the initiation trial chart and maintenance and monitoring chart. We modified the layout and were able to add four rows at the bottom of the chart for 1) complications (reviewed yes/no), 2) aberrant behavior (reviewed yes/no), 3) urine drug screening (yes/no), and 4) other medications.
Another recurrent theme was the suggestion to integrate the OPIOID MANAGER into Electronic Medical Record (EMR) systems most commonly used in Canada. 2 percent) , and 309 miscellaneous (21.6 percent), which included 93 nurses, 33 pharmaceutical industry representatives, 18 students, 10 residents, 12 patients or patients' relatives, 10 physician assistants, five general public, three lawyers, two law enforcements, two EMR vendors, two chief medical officers, etc. In addition to the number of downloads, we have also monitored the number of paper copies that have been distributed; as of May 2011, at least 3,000 paper copies have been distributed across Canada. These copies have been distributed at conferences, meetings, workshops, rounds, and continuing medical education activities.
The OPIOID MANAGER VIDEO
Utilization of the OPIOID MANAGER
The primary intended use of the OPIOID MANAGER was to enable guideline-based decision making at point of care by providers prescribing and dispensing opioids for chronic noncancer pain. In addition, the OPIOID MANAGER has been used as an educational tool to teach about the key messages contained in the Canadian Opioid Guideline. The OPIOID MAN-AGER is divided into four parts that match the following four most common clinical questions that physicians have when prescribing opioids for chronic noncancer pain: 
Integration of the OPIOID MANAGER into EMRs
The OPIOID MANAGER has been integrated to X-WAVE® and Practice Solutions Suite®. These two full integrations are being tested in Ontario. The OPIOID MANAGER has been partially integrated to Optimed® and is being tested in Saskatchewan.
Translations of the OPIOID MANAGER to other languages
Official translations of the OPIOID MANAGER are underway and will include French (Canadian), Spanish (South America), Portuguese (Brazil), and Farsi (Iran). Once these translations are completed, they will be posted on the OPIOID MANAGER's webpage for free download.
DISCUSSION
The OPIOID MANAGER is a tool that can be used by healthcare providers, including primary care physicians, specialists, nurses, policy makers, and pharmacists. It can also be used as an educational tool to teach medical students, residents, and professionals in practice pursuing continuing education. The Canadian Opioid Guideline contains many other tools and instruments that were not included in the OPIOID MANAGER, such as a recommended tool to monitor functional changes, a benzodiazepine tapering protocol, information about urine drug screening detection times, and other instruments to assess the risk of opioid misuse, abuse, and addiction.
The main limitations of the OPIOID MANAGER are that it is a paper-based tool and many medical offices have adopted EMRs, therefore, the eminent need to integrate the OPIOID MANAGER to EMRs. However, each EMR has its own technical requirements, and integration of a tool like this needs to be carefully implemented and evaluated. Many users have expressed concerns that the OPIOID MAN-AGER contains too much information, and it is unreasonable to ask physicians to fill all of its fields with every patient. This problem has been addressed in the OPIOID MANAGER VIDEO and explained that although it might look like a busy tool, once the user becomes familiar with it, it is easier to use. Also, it is not required that all fields be completed for every patient in one visit. The prescriber may use the information contained in the OPIOID MANAGER as a guide to what is important to assess and document at various points during the opioid prescribing activities.
The OPIOID MANAGER is out-of-date 1 year after its release because some opioids, for example, buprenorphine patch, tapentadol, and oxymorphone, have been introduced in the Canadian market after the release of the Canadian Opioid Guideline and are not mentioned in the OPIOID MANAGER. Although there is no planned further revision to the OPIOID MANAGER in the near future, we will evaluate the effectiveness of the OPIOID MANAGER to improve patient' outcomes, satisfaction with treatment, and physicians comfort and confidence levels with the addition of the OPIOID MANAGER to their practices. We will continue monitoring the use of the OPIOID MANAGER by the individuals who download it from the Guideline's Web site.
